-
3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma
- October 28, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Africa, Latin America and Specialty Drug Stocks with a strong future roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Specialty Branded Generics Company, Domestic Pharma Volume Leader and Overseas Formulations Maker Stocks With a Strong Future Roadmap: Ajanta Pharma, Mankind Pharma and Marksans Pharma
- October 28, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Branded Generic and Formulation Exporter Stocks with a strong future roadmap: Ajanta Pharma, Mankind Pharma and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Specialty Branded Generics Seller, Respiratory and Anti-Infective Leader and Research-Driven Pharma Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Cipla and Glenmark Pharmaceuticals
- October 27, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Eye Care, Respiratory and Research Pharma Stocks with a strong future roadmap: Ajanta Pharma, Cipla and Glenmark Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Cardiac Brands Specialist, Emerging Markets Generics Seller and High-Volume Ingredients Producer Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Ajanta Pharma and Granules India
- October 27, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Cardiac Brand and Ingredient Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Ajanta Pharma and Granules India. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Global Generics Leader, Specialty Branded Generics Seller and Pain and Anti-Malarial Brand Owner Stocks With a Strong Future Roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Global Generic and Specialty Pharma Stocks with a strong future roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Regulated-Market Generics Maker, Specialty Branded Generics Seller and Large Active Ingredients Producer Stocks With a Strong Future Roadmap: Strides Pharma Science, Ajanta Pharma and Divi’s Laboratories
- October 26, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Generic Formulation and API Pharma Stocks with a strong future roadmap: Strides Pharma Science, Ajanta Pharma and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Specialty Branded Generics, Global Generics and Injectables and Cardiac Therapy Leader Stocks With a Strong Future Roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals
- October 23, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Branded Generic and Global Formulation Stocks with a strong future roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Oncology and Biologics, Formulation Outsourcing and Eye and Skin Care Brands Stocks With a Strong Future Roadmap: Shilpa Medicare, Innova Captab and Ajanta Pharma
- October 22, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Oncology and Contract Pharma Stocks with a strong future roadmap: Shilpa Medicare, Innova Captab and Ajanta Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Contract Research Partner, Specialty Formulations and Branded Generics Stocks With a Strong Future Roadmap: Sai Life Sciences, Rubicon Research and Ajanta Pharma
- October 22, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Specialty Pharma and Research Services Stocks with a strong future roadmap: Sai Life Sciences, Rubicon Research and Ajanta Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Ophthalmic Brands, Cancer Generics and Pharma Excipients Stocks With a Strong Future Roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Oncology and Excipient Pharma Stocks with a strong future roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.